Agilent Technologies Stock News

Fifth Third Bancorp decreased its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 3.2% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 65,488 shares of the medical research companys stock after selling 2,136 shares during the quarter. Fifth Third Bancorps holdings in Agilent []

Global Prepacked Chromatography Columns market Overview Single-use innovations make manufacturing simpler with prepackaged chromatography columns. Equipment capital and qualification, asset traceability, calibration, and routine maintenance are all eliminated with these columns. Prepackaged chromatography columns often save money on materials and consumables associated

A biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that permits many tests to be performed at the same time in order to achieve higher throughput and speed. Biochip Technology Market is estimated to

Pacer Advisors Inc. increased its holdings in Agilent Technologies, Inc. (NYSE:A) by 24.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 35,505 shares of the medical research companys stock after acquiring an additional 6,937 shares during the period. []

DUBLIN--(BUSINESS WIRE)--The "Endocrine Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com''s offering. The global endocrine testing market reached a value of US$ 10 Billion in 2020. Looking forward, the publisher expects the market to grow at a CAGR of 8.7% during 2021-2026. Companies Mentioned Abbott Laboratories Agilent Technologies Inc. Bio-Rad Laboratories Inc. BioMerieux SA DiaSorin S.p.A. F. Hoff

The global Cell Analysis Technology market size is projected to a CAGR of 14.2% during 2021-2027. Worldwide Cell Analysis Technology Market 2021-2027 industry report examines the development openings just as the dangers to the Cell Analysis Technology Market w.r.t Business

DNA microarrays are microscope slides that are printed with thousands of tiny spots in defined positions, with each spot containing a known DNA sequence or gene. The two mRNA samples are then converted into complementary DNA (cDNA), and each sample

Global Molecular Spectroscopy Market Synopsis: Research analysts accomplish smart, resourceful and engaging surveys while creating Molecular Spectroscopy Market report that are sure to provide the better results. By leveraging the use of smart strategies and formats, the report helps businesses gain

Equities research analysts predict that Agilent Technologies, Inc. (NYSE:A) will report earnings per share of $1.17 for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for Agilent Technologies earnings, with the highest EPS estimate coming in at $1.19 and the lowest estimate coming in at $1.16. Agilent Technologies posted earnings []

Global Biochips Market Overview: The top-notch Biochips Market research report has been structured by skilful and experienced team players who work hard to accomplish an absolute growth and success in the business. The Marketing report acts upon Market study and analysis

Atomic absorption spectroscopy (AAS) is a spectroanalytical procedure for the quantitative determination of chemical elements using the absorption of optical radiation (light) by free atoms in the gaseous state. The classification of Atomic Absorption Spectroscopy Instrument includes Flame, Graphite Furnace, Other.

Agilent Technologies (NYSE:A) had its price objective hoisted by Cowen from $180.00 to $187.00 in a report issued on Tuesday, Price Targets.com reports. They currently have an outperform rating on the medical research companys stock. A number of other analysts have also recently commented on A. SVB Leerink boosted their target price on shares of []

Agilent Technologies, Inc. (NYSE:A) Investment analysts at Jefferies Financial Group lowered their Q2 2022 EPS estimates for Agilent Technologies in a note issued to investors on Tuesday, November 23rd. Jefferies Financial Group analyst B. Couillard now expects that the medical research company will earn $1.07 per share for the quarter, down from their prior [] The post Agilent Technologies, Inc. Forecasted to Post Q2 2022 Earnings of $1.07 Per Share (NYSE:A) appeared first on ETF Daily News .